Haemonetics specializes in innovative medical technology solutions aimed at enhancing the quality, effectiveness, and efficiency of healthcare. Their offerings include advanced technologies for plasma collection centers that optimize operations by increasing plasma yield and improving donor experiences. Additionally, Haemonetics provides hospitals with solutions designed to enhance clinical outcomes and procedural effectiveness, thereby advancing healthcare standards. Their commitment to driving efficiency extends to blood centers, where they focus on ensuring blood safety and improving operational processes to meet the demand for critical blood components.

The company also emphasizes the importance of technical support and software solutions, ensuring that their medical devices function optimally through validated software releases and third-party software integration. Haemonetics is dedicated to maintaining high standards in product support and customer service, providing regional technical assistance and guidance on software patches. This comprehensive approach to technology and support underscores Haemonetics' mission to make a meaningful impact in patient care and healthcare delivery.

United States

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Haemonetics

Company Details